Delivery Order SPE2DR25D3103-SPE2DR26F9Z80
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order on July 15, 2025, for the supply of Thrombin-JMI 5,000 Units vials with a ceiling value of $1,188.00. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement by the Medical Supply Chain, which operates under the Defense Logistics Agency within the Department of Defense. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Thrombin-JMI 20,000 unit vials valued at $27,094.51 with a completion date of January 23, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 5,000 Units Vials on April 23, 2025, with a ceiling value of $1,334.80. This competitively awarded, firm fixed price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a $3,195 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This contract, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a small-value pharmaceutical procurement to support federal medical supply requirements. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established position as a critical vendor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for Thrombin-JMI 5,000 unit epistaxis products valued at $1,639.81. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,765.48 firm fixed-price delivery order is for the supply of 20,000-unit vials of the drug Thrombin-JMI. The contract has an ultimate completion date of November 30, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS, a specialty pharmaceutical product. The contract, valued at $5,928.00, was awarded by the Defense Logistics Agency (DLA) as a delivery order with a firm fixed price. The contract has an ultimate completion date of February 8, 2024. There is no set-aside designation for this award. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,357.48 firm-fixed-price delivery order is for the supply of 20,000 unit vials of the thrombin-jmi medication. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024 with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 contract vehicle that enables efficient procurement of essential pharmaceutical and medical supplies for military healthcare programs globally. The contract covers the...
- This federal contract award, valued at $12,472.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4558286079 - THROMBIN-JMI 20,000 UNIT VIALS and has an ultimate completion date of August 31, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...